A couple of interesting points in this presentation
- • 1Q FY21 on track to report sales growth of +25% above 4Q FY20
- Can now sell to select customers in the US under a section lVc exemption until FDA EUA is received
- Targeting first US customer contract for SARS-COV2 product
A couple of interesting points in this presentation- • 1Q FY21...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $74.95M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 33.0¢ | $9.84K | 29.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 548 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 5203 | 2 |
View Market Depth
| Last trade - 15.00pm 29/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |